Interpreting pigmentation changes after regenerative procedures

This edited account distinguishes personal experience, laboratory research and clinical studies. Individual suitability requires clinical assessment.

The source considers pigmentation changes after procedures intended for skin regeneration. It connects cells, growth factors and needle-related irritation with melasma, but stem cells, PRP and exosomes are different materials and research categories.

The report on SCF and c-KIT expression in melasma lesions (PMID 16704639) is not a direct trial showing that a particular procedure worsens melasma. Molecular observations cannot establish the benefits or adverse-event rates of all regenerative procedures.

The source asks clinicians to distinguish procedural inflammation, ultraviolet exposure, hormones, medication history and other conditions. Improvement after several combined approaches cannot readily be attributed to one preparation.

Medicines such as tamoxifen are relevant to assessment and should not be stopped independently because of skin changes. Tranexamic acid, vitamin C and infusions in the source are not reproduced as general prescriptions. The purpose is to consider evidence and procedural conditions together in pigmented skin.